未登录

S

Saiyuri Naicker

University of Queensland

H指数:9

被引数:191

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A review of antimicrobial stability testing guidance for outpatient parenteral antimicrobial therapy programmes: is it time for global harmonization of testing frameworks?

JAC-ANTIMICROBIAL RESISTANCE

IF3.3

2024-11-280

OAAI

Evaluation of the stability of ceftazidime/avibactam in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy utilizing a national stability protocol framework

JAC-ANTIMICROBIAL RESISTANCE

IF3.3

2024-04-052

OAAI

An in vitro dynamic bioreactor model for evaluating antimicrobial effectiveness on periodontal polymicrobial biofilms: a proof-of-concept study

JOURNAL OF PERIODONTOLOGY

IF3.8

2023-09-196

OAAI

Evaluation of Fosfomycin-Sulbactam Combination Therapy against Carbapenem-Resistant Acinetobacter baumannii Isolates in a Hollow-Fibre Infection Model

ANTIBIOTICS-BASEL

IF4.6

2022-11-098

OA

Pharmacodynamics of Piperacillin-Tazobactam/Amikacin Combination versus Meropenem against Extended-Spectrum β-Lactamase-Producing Escherichia coli in a Hollow Fiber Infection Model

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2022-09-207

OA

Pharmacodynamic evaluation of intermittent versus extended and continuous infusions of piperacillin/tazobactam in a hollow-fibre infection model against Escherichia coli clinical isolates

在针对大肠杆菌临床分离株的中空纤维感染模型中，间歇性和长期和连续输注哌拉西林/他唑巴坦的药效学评估

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

IF3.6

2022-08-292

PRE

Evaluating Mono- and Combination Therapy of Meropenem and Amikacin against Pseudomonas aeruginosa Bacteremia in the Hollow-Fiber Infection Model

MICROBIOLOGY SPECTRUM

IF3.8

2022-06-299

OAAI

Use of the Hollow-Fiber Infection Model to Measure the Effect of Combination Therapy of Septic Shock Exposures of Meropenem and Ciprofloxacin against Intermediate and Resistant Pseudomonas aeruginosa Clinical Isolates

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2022-05-171

OA

Pharmacodynamic Evaluation of a Single Dose versus a 24-Hour Course of Multiple Doses of Cefazolin for Surgical Prophylaxis

ANTIBIOTICS-BASEL

IF4.6

2021-05-194

OAAI

Pharmacodynamic Evaluation of Plasma and Epithelial Lining Fluid Exposures of Amikacin against Pseudomonas aeruginosa in a Dynamic In Vitro Hollow-Fiber Infection Model

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2020-08-209

OAAI

Pharmacodynamic evaluation of intermittent versus extended and continuous infusions of piperacillin/tazobactam in a hollow-fibre infection model against Klebsiella pneumoniae

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

IF3.6

2020-06-2513

OAAI

A UHPLC-MS/MS method for the simultaneous determination of piperacillin and tazobactam in plasma (total and unbound), urine and renal replacement therapy-effluent

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

IF3.1

2018-01-0125

PREAI